Striatal hand in Parkinson’s disease: the re-evaluation of an old clinical sign
Francesca Spagnolo(Department of Medical Sciences), Maria Antonietta Volonté(Vita-Salute San Raffaele University), Sebastiano Bucello, Mario Fichera(Fondazione IRCCS Istituto Neurologico Carlo Besta), Lidia Sarro(Fondazione IRCCS Istituto Neurologico Carlo Besta), Letizia Leocani(Vita-Salute San Raffaele University), Gıancarlo Comı(Casa di Cura Columbus), Matteo Impellizzeri(Vita-Salute San Raffaele University), Elise Houdayer(San Raffaele University of Rome), Damiano Baroncini, Emanuela Leopizzi(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University)
Cited by 16
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
|Clinical Neurophysiology|2020|1.5k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706